| scholarly article | Q13442814 |
| P2093 | author name string | Jun Lee | |
| Philippe Grimbert | |||
| Dominique Desvaux | |||
| Choli Hartono | |||
| Surya V Seshan | |||
| Thangamani Muthukumar | |||
| Darshana M Dadhania | |||
| David Serur | |||
| Marie Matignon | |||
| John R Lee | |||
| Pallavi Patri | |||
| P2860 | cites work | The clinical impact of chronic transplant glomerulopathy in cyclosporine era. | Q46845020 |
| On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI. | Q47745531 | ||
| Clinical, Histological, and Molecular Markers Associated With Allograft Loss in Transplant Glomerulopathy Patients. | Q50960261 | ||
| Transplant glomerulopathy: it's not always about chronic rejection. | Q55054954 | ||
| The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
| IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients | Q68807864 | ||
| The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis | Q70225378 | ||
| Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies | Q81414156 | ||
| Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy | Q83410113 | ||
| Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts | Q84139761 | ||
| Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab | Q87378832 | ||
| Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection | Q87524072 | ||
| Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy | Q33395896 | ||
| Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. | Q34181871 | ||
| The histology of kidney transplant failure: a long-term follow-up study. | Q34439824 | ||
| The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification | Q34658768 | ||
| Histopathologic classification of ANCA-associated glomerulonephritis | Q34660132 | ||
| Transplant glomerulopathy | Q37092282 | ||
| Transplant glomerulopathy: clinical course and factors relating to graft survival | Q38059296 | ||
| Advances in the understanding of transplant glomerulopathy | Q38073507 | ||
| Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name? | Q38195716 | ||
| Transplant glomerulopathy: the interaction of HLA antibodies and endothelium | Q38205229 | ||
| Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection | Q38282840 | ||
| Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy. | Q39151972 | ||
| Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. | Q41849097 | ||
| Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation | Q42247863 | ||
| Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | Q43580802 | ||
| Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation | Q45627897 | ||
| Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. | Q45966400 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 450-458 | |
| P577 | publication date | 2015-09-30 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy | |
| P478 | volume | 89 |
| Q37698860 | Antibody-Mediated Rejection: A Review |
| Q92369328 | Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival |
| Q91677112 | Banff lesions and renal allograft survival in chronic-active antibody mediated rejection |
| Q64226624 | Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy |
| Q47876027 | Morphologic patterns and treatment of transplant glomerulopathy: A retrospective analysis |
| Q50063069 | Transplant glomerulopathy |
| Q65000602 | Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection. |
Search more.